Michael Zinda, EVP, CHIEF SCIENTIFIC OFFICER at Repare Therapeutics Inc. (RPTX), sold 5,611 shares at $1.14 ($6K) on 2025-03-12, disclosed to the SEC on 2025-03-14.
Open-market sale of $6k RPTX by EVP, CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPTX | SELL | 2023-06-09 | $189K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |
| RPTX | SELL | 2022-03-16 | $6K | — | Filing → |